March 2014 Blog Posts (7)

Avoiding Financial Decline due to Cancer Treatment Requires More and Better Communication Between Doctor and Patient

A new study led by University of Michigan Comprehensive Cancer Center researchers shows the financial impact of cancer treatment. Four years after being treated for breast cancer, a quarter of survivors say they are worse off financially, at least partly because of their treatment. An additional 12% reported that they still have medical debt from their treatment.

The researchers found that financial decline varied significantly by race, with Spanish-speaking Latinas most…

Continue

Added by Editorial Team on March 25, 2014 at 12:30pm — No Comments

New Anticancer Drug Manipulating the Body's Natural Signaling and Energy System Dramatically Improves Cancer Survival

A revolutionary breakthrough in the treatment of cancer could soon be underway following an important discovery which may lead to a dramatic improvement in cancer survival rates.

A new study published today in the International edition of Angewandte Chemie, reports how researchers at the University of Warwick have developed a new drug that can manipulate the body's natural signaling and energy systems, allowing the body to attack and shut down cancerous…

Continue

Added by Editorial Team on March 25, 2014 at 10:00am — No Comments

Multiplex Tumor Genomic Testing - How Physicians Will Use Tests in Practice.

Many cancer researchers believe that cutting-edge advances in genomics will pave the way for "personalized" or "precision" cancer medicine for all patients in the near future. A new study by researchers at Dana-Farber Cancer Institute, however, suggest that not all doctors are ready to embrace tests that look for hundreds of DNA changes in patients' tumor samples, while others plan to offer this type of cancer gene testing to most of their patients. The findings are published in the…

Continue

Added by Editorial Team on March 24, 2014 at 2:00pm — No Comments

Does PSA-testing and Early Treatment Decreases Risk of Prostate Cancer Death?

Prostate cancer is second leading cause of cancer death in Western world. Each year, around the world, over 670,000 men are diagnosed with the disease. In the United States, there were 238,590 new cases of prostate cancer in 2013. Nearly 30,000 men died of the disease in the U.S. in that year. Now a study published online in Journal of the National Cancer Institute by researchers from Umeå University, Sweden and…

Continue

Added by Editorial Team on March 10, 2014 at 11:30am — No Comments

Market Analysis Shows Importance of Targeted Therapies

By Brianza Nyborg (Contributing Author)

A new market research report published earlier this year by Reportlinker.com discusses the increased importance of targeted therapies in the treatment of patients with cancer. The report describes how changes the availability of thearpies is expected to influence…

Continue

Added by Editorial Team on March 3, 2014 at 10:00pm — No Comments

The Link Between Colorectal Cancer and Gut Microbes

It is not only genetics that predispose to bowel cancer. According to new research in mice published in the March 3, 2014 issue of JEM/The Journal of Experimental Medicine, microbes living in the gut help drive the development of intestinal tumors.

Bowel cancer, also called colon or colorectal cancer, is the third most common non-skin cancer and the second leading cause of cancer-related mortality in men and women in the United States. The available data shows that over the…

Continue

Added by Editorial Team on March 3, 2014 at 1:30pm — No Comments

CDK 4 and 6 Inhibitor Palbociclib plus Letrozole in Women with Advanced Breast Cancer Shows Clinical Benefit

The randomized Phase II multi-center PALOMA-1 trial of palbociclib achieved its primary endpoint by demonstrating a statistically significant and clinically meaningful improvement in progression-free survival (PFS) for the combination of palbociclib (125 mg once daily for three out of four weeks in repeated cycles) and letrozole compared with letrozole alone (2.5 mg once daily on a continuous regimen) in post-menopausal women with estrogen receptor positive (ER+), human…

Continue

Added by Editorial Team on March 3, 2014 at 12:30am — No Comments

Monthly Archives

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2005

2004

2001

Register for free to view all the Onco'Zine - The International Oncology Network content:

ADVERTISEMENT/MEDIA PARTNER

Onco'Zine is present here

Bookmark / Share

CONNECT WITH US AND

JOIN THE CONVERSATION


© 2017   Created by Peter Hofland, PhD.   Powered by

Badges  |  Report an Issue  |  Terms of Service

Find us on Google+